急性冠状动脉综合征早期他汀类药物的应用价值

[1] The role of inflammation markers in triggering acute coronary events [J]. HEART AND VESSELS, 2003, 18 (04) : 171 - 176

[2] Lipid-lowering therapies in the management of acute coronary syndromes [J]. Current Cardiology Reports, 2002, 4 (4) : 320 - 326

[3] For the cholesterol and Recurrent Even（tCARE）investigators, Pravastatin Prevents clinical events in revascularized patients with average cholesterol concentrations. Flaker GC,Warnica JW,Sacks FW,et al. Journal of the American College of Cardiology . 1999

[4] Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study（4S）. Pederson JR, Olsson AG, Faergeman V, et al. Circulation . 1998

[5] Beneficial effects of cholesterollowering therapy on the coronary endothelium in patients with coronary artery disease. Treasure CB, Klein JL, Weintraub WS, et al. The New England Journal of Medicine . 1995

[6] Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrowderived endothelial progenitor cells. Walter DD, Rittig K, Bahlmann FH. Circulation . 2002

[7] Lipid-lowering therapy with fluvastain inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients. Inoue T, Hayashi M, Takayanagi K, et al. Atherosclerosis . 2002

[1] The role of inflammation markers in triggering acute coronary events [J]. HEART AND VESSELS, 2003, 18 (04) : 171 - 176

[2] Lipid-lowering therapies in the management of acute coronary syndromes [J]. Current Cardiology Reports, 2002, 4 (4) : 320 - 326

[3] For the cholesterol and Recurrent Even（tCARE）investigators, Pravastatin Prevents clinical events in revascularized patients with average cholesterol concentrations. Flaker GC,Warnica JW,Sacks FW,et al. Journal of the American College of Cardiology . 1999

[4] Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study（4S）. Pederson JR, Olsson AG, Faergeman V, et al. Circulation . 1998

[5] Beneficial effects of cholesterollowering therapy on the coronary endothelium in patients with coronary artery disease. Treasure CB, Klein JL, Weintraub WS, et al. The New England Journal of Medicine . 1995

[6] Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrowderived endothelial progenitor cells. Walter DD, Rittig K, Bahlmann FH. Circulation . 2002

[7] Lipid-lowering therapy with fluvastain inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients. Inoue T, Hayashi M, Takayanagi K, et al. Atherosclerosis . 2002